\ General \ ALS Research Comes of Age: ALS Journal Appoints New Editorial Team
The WFN Research Group facilitates collaboration across borders defined by both geography and discipline. The ALS Journal is the only publication for this rapidly progressive neurodegenerative disease, and subscription is available as a benefit to members of the WFN Research Group on ALS/MND.
“Working together as a community of clinicians, scientists and care providers, we must continue to strive to make a difference in the lives of people with ALS. As the incoming editor, I, with the new editorial board, will do my best to attract and publish research that will help to make that difference a reality,” says Hardiman.
For more information about the ALS Journal, and to become a subscriber, visit http://www.informaworld.com/als.
For more information about the World Federation of Neurology Research Group on ALS/MND, visit http://www.wfnals.org
|
|
Click Here For A Printer Friendly Version Of This Page
ALS Research Comes of Age: ALS Journal Appoints New Editorial Team
The ALS Journal, the official publication of the World Federation of Neurology (WFN) Research Group on ALS/MND, is undergoing a mini-makeover, reflecting exciting change in the pace of ALS research. A new editor, neurologist Orla Hardiman from Dublin, Ireland has been appointed. Together with associate editors Denise Figlewicz, PhD, director of research at the ALS Society of Canada in Toronto, Canada, and Reinhard Dengler, MD, professor of neurology and chair of the Department of Neurology at Hannover Medical School in Germany, and the new editorial board drawn from across the world of ALS clinicians and scientists, the ALS Journal will provide regular in-depth reviews of “hot topics,” in addition to encouraging rapid dissemination of peer reviewed clinical, translational and basic science research of high quality.The WFN Research Group facilitates collaboration across borders defined by both geography and discipline. The ALS Journal is the only publication for this rapidly progressive neurodegenerative disease, and subscription is available as a benefit to members of the WFN Research Group on ALS/MND.
“Working together as a community of clinicians, scientists and care providers, we must continue to strive to make a difference in the lives of people with ALS. As the incoming editor, I, with the new editorial board, will do my best to attract and publish research that will help to make that difference a reality,” says Hardiman.
For more information about the ALS Journal, and to become a subscriber, visit http://www.informaworld.com/als.
For more information about the World Federation of Neurology Research Group on ALS/MND, visit http://www.wfnals.org
| Posted On: Tuesday, January 29, 2008 Modified: Tuesday, January 29, 2008 Category: General Posted By: |